Literature DB >> 16825189

Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha.

Xunshan Ding1, Kristin Lichti, Insook Kim, Frank J Gonzalez, Jeff L Staudinger.   

Abstract

Animal studies reveal that fasting and caloric restriction produce increased activity of specific metabolic pathways involved in resistance to weight loss in liver. Evidence suggests that this phenomenon may in part occur through the action of the constitutive androstane receptor (CAR, NR1I3). Currently, the precise molecular mechanisms that activate CAR during fasting are unknown. We show that fasting coordinately induces expression of genes encoding peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha), CAR, cytochrome P-450 2b10 (Cyp2b10), UDP-glucuronosyltransferase 1a1 (Ugt1a1), sulfotransferase 2a1 (Sult2a1), and organic anion-transporting polypeptide 2 (Oatp2) in liver in mice. Treatments that elevate intracellular cAMP levels also produce increased expression of these genes in cultured hepatocytes. Our data show that PGC-1alpha interaction with hepatocyte nuclear factor 4alpha (HNF4alpha, NR2A1) directly regulates CAR gene expression through a novel and evolutionarily conserved HNF4-response element (HNF4-RE) located in its proximal promoter. Expression of PGC-1alpha in cells increases CAR expression and ligand-independent CAR activity. Genetic studies reveal that hepatic expression of HNF4alpha is required to produce fasting-inducible CAR expression and activity. Taken together, our data show that fasting produces increased expression of genes encoding key metabolic enzymes and an uptake transporter protein through a network of interactions involving cAMP, PGC-1alpha, HNF4alpha, CAR, and CAR target genes in liver. Given the recent finding that mice lacking CAR exhibit a profound decrease in resistance to weight loss during extended periods of caloric restriction, our findings have important implications in the development of drugs for the treatment of obesity and related diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16825189      PMCID: PMC2991045          DOI: 10.1074/jbc.M600931200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

Review 1.  Thyroid hormone action in the heart.

Authors:  George J Kahaly; Wolfgang H Dillmann
Journal:  Endocr Rev       Date:  2005-01-04       Impact factor: 19.871

Review 2.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

3.  Thyroid hormone export from cells: contribution of P-glycoprotein.

Authors:  A M Mitchell; M Tom; R H Mortimer
Journal:  J Endocrinol       Date:  2005-04       Impact factor: 4.286

4.  The ratio of constitutive androstane receptor to pregnane X receptor determines the activity of guggulsterone against the Cyp2b10 promoter.

Authors:  Xunshan Ding; Jeff L Staudinger
Journal:  J Pharmacol Exp Ther       Date:  2005-04-15       Impact factor: 4.030

5.  Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats.

Authors:  Harvey Wong; Lois D Lehman-McKeeman; Mary F Grubb; Scott J Grossman; Vasanthi M Bhaskaran; Eric G Solon; Helen S L Shen; Ronald J Gerson; Bruce D Car; Bitao Zhao; Brian Gemzik
Journal:  Toxicol Sci       Date:  2005-01-26       Impact factor: 4.849

6.  Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha.

Authors:  Christoph Handschin; Jiandie Lin; James Rhee; Anne-Kathrin Peyer; Sherry Chin; Pei-Hsuan Wu; Urs A Meyer; Bruce M Spiegelman
Journal:  Cell       Date:  2005-08-26       Impact factor: 41.582

7.  Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism.

Authors:  Mohammed Qatanani; Jun Zhang; David D Moore
Journal:  Endocrinology       Date:  2004-11-24       Impact factor: 4.736

8.  Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha.

Authors:  Yusuke Inoue; Ai-Ming Yu; Sun Hee Yim; Xiaochao Ma; Kristopher W Krausz; Junko Inoue; Charlie C Xiang; Michael J Brownstein; Gösta Eggertsen; Ingemar Björkhem; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2005-11-01       Impact factor: 5.922

9.  Transcriptional regulation of human UGT1A1 gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1.

Authors:  Junko Sugatani; Shinichi Nishitani; Kasumi Yamakawa; Kouichi Yoshinari; Tatsuya Sueyoshi; Masahiko Negishi; Masao Miwa
Journal:  Mol Pharmacol       Date:  2004-11-22       Impact factor: 4.436

10.  Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity.

Authors:  Yuzhi Jia; Grace L Guo; Sailesh Surapureddi; Joy Sarkar; Chao Qi; Dongsheng Guo; Jun Xia; Papreddy Kashireddi; Songtao Yu; Young-Wook Cho; M Sambasiva Rao; Byron Kemper; Kai Ge; Frank J Gonzalez; Janardan K Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

View more
  54 in total

1.  CAR Suppresses Hepatic Gluconeogenesis by Facilitating the Ubiquitination and Degradation of PGC1α.

Authors:  Jie Gao; Jiong Yan; Meishu Xu; Songrong Ren; Wen Xie
Journal:  Mol Endocrinol       Date:  2015-09-25

2.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

Authors:  J P Hernandez; L C Mota; W S Baldwin
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

Review 3.  Sterol regulation of metabolism, homeostasis, and development.

Authors:  Joshua Wollam; Adam Antebi
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

Review 4.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

Review 5.  Allosteric pathways in nuclear receptors - Potential targets for drug design.

Authors:  Elias J Fernandez
Journal:  Pharmacol Ther       Date:  2017-10-31       Impact factor: 12.310

6.  Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis.

Authors:  Supriya R Kulkarni; Carol J Soroka; Lee R Hagey; James L Boyer
Journal:  Hepatology       Date:  2016-10-28       Impact factor: 17.425

Review 7.  Hepatocyte nuclear factor 4alpha regulation of bile acid and drug metabolism.

Authors:  John Y L Chiang
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-02       Impact factor: 4.481

8.  Cyclic AMP-dependent protein kinase signaling modulates pregnane x receptor activity in a species-specific manner.

Authors:  Kristin Lichti-Kaiser; Chenshu Xu; Jeff L Staudinger
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

9.  Hepatocyte nuclear factor 4{alpha} regulates rifampicin-mediated induction of CYP2C genes in primary cultures of human hepatocytes.

Authors:  Ritu Rana; Yuping Chen; Stephen S Ferguson; Grace E Kissling; Sailesh Surapureddi; Joyce A Goldstein
Journal:  Drug Metab Dispos       Date:  2010-01-19       Impact factor: 3.922

10.  p38 Mitogen-activated protein kinase regulates nuclear receptor CAR that activates the CYP2B6 gene.

Authors:  Kosuke Saito; Rick Moore; Masahiko Negishi
Journal:  Drug Metab Dispos       Date:  2013-03-28       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.